Direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection: Interferon free is now.
about
Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective TherapyEfficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection.The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions.Hepatitis C virus whole genome sequencing: Current methods/issues and future challenges.Developing and Using Therapeutics for Emerging Infections.Nephrotoxicity Associated with Concomitant Use of Ledipasvir-Sofosbuvir and Tenofovir in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection.
P2860
Direct-acting antiviral drugs for the treatment of chronic hepatitis C virus infection: Interferon free is now.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Direct-acting antiviral drugs ...... ction: Interferon free is now.
@en
type
label
Direct-acting antiviral drugs ...... ction: Interferon free is now.
@en
prefLabel
Direct-acting antiviral drugs ...... ction: Interferon free is now.
@en
P2093
P2860
P356
P1476
Direct-acting antiviral drugs ...... ction: Interferon free is now.
@en
P2093
P2860
P304
P356
10.1002/CPT.185
P407
P50
P577
2015-07-14T00:00:00Z